Clinical Trial Update: A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating four cycles of neoadjuvant chemotherapy followed by concurrent chemoradiation in N2-3 nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN